Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) FCF Margin (2023 - 2025)

Mereo BioPharma (MREO) has disclosed FCF Margin for 2 consecutive years, with 26103.57% as the latest value for Q3 2025.

  • On a quarterly basis, FCF Margin changed N/A to 26103.57% in Q3 2025 year-over-year; TTM through Sep 2025 was 11208.56%, a 818826.0% decrease, with the full-year FY2023 number at 211.32%, changed N/A from a year prior.
  • FCF Margin was 26103.57% for Q3 2025 at Mereo BioPharma, up from 1530.2% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 26103.57% in Q3 2025 to a low of 1530.2% in Q2 2025.